Vicarious Surgical Inc Stock Price, News & Analysis

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announced its participation in the Cowen 7th Annual FutureHealth Conference. Management will present on June 22 at 10:50 a.m. ET, and a live webcast will be accessible on the company’s website. Founded in 2014 and headquartered in Waltham, Massachusetts, Vicarious Surgical develops advanced robotics technology aimed at improving patient outcomes and reducing healthcare costs through minimally invasive surgeries.

Vicarious Surgical announced its financial results for Q1 2022, reporting a substantial increase in operating expenses to $18.2 million from $5.2 million in Q1 2021, marking a 248% rise. R&D costs rose to $9.8 million, while general and administrative expenses reached $6.9 million. The adjusted net loss was $18.2 million, or $0.15 per share, compared to a loss of $5.2 million, or $0.06 per share, in the previous year. Notably, GAAP net income was $42.5 million, translating to net income per share of $0.35. The company continues to advance its Vicarious System with successful beta testing.

Vicarious Surgical Inc. (NYSE: RBOT) announced it will report financial results for Q1 2022 after market close on May 9, 2022. Management will host a conference call at 4:30 p.m. Eastern Time. Investors can participate by calling +1 (646) 904 5544 for domestic or +1 (929) 526 1599 for international access using code: 646287. The company focuses on enhancing surgical procedures' efficiency and outcomes using proprietary robotic technology. Founded in 2014 and based in Waltham, Massachusetts, Vicarious Surgical is backed by notable investors including Bill Gates.

Vicarious Surgical, Inc. (NYSE:RBOT) has successfully qualified its cleanroom for manufacturing the Vicarious System, enhancing its capabilities for precision assembly. This qualification ensures adherence to stringent efficiency and quality standards, marking a significant step towards market readiness. The Vicarious System aims to improve surgical outcomes by facilitating procedures through a single port, promoting faster patient recovery. CEO Adam Sachs emphasized the importance of a quality-controlled manufacturing process in achieving better healthcare outcomes.

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announced the appointment of John Mazzola as vice president of operations. With over 30 years in the medical device industry, Mazzola aims to enhance the company’s manufacturing strategies for its next-generation surgical robotics. Prior to joining Vicarious, he held senior roles at Becton Dickinson, overseeing 10 manufacturing sites. CEO Adam Sachs expressed confidence in Mazzola's expertise to drive operational growth. Mazzola's active involvement in industry associations adds to his credentials.

Vicarious Surgical (NYSE: RBOT, RBOT WS) reported preliminary unaudited financial results for Q4 and the full year 2021. The company experienced a significant increase in operating expenses, totaling $18.2 million in Q4, up 380% year-over-year. Adjusted net loss for Q4 was $18.2 million, or $0.15 per share, compared to a loss of $3.8 million, or $0.04 per share in the prior year. Full year operating expenses reached $38.6 million, reflecting a 197% increase. Cash and cash equivalents stood at $173.5 million as of December 31, 2021.

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announced its participation in two upcoming virtual investor conferences. The Cowen 42nd Annual Healthcare Conference will feature a presentation on Tuesday, March 8, at 9:10 a.m. ET. Additionally, the Oppenheimer 32nd Annual Healthcare Conference is scheduled for Wednesday, March 16, at 8:40 a.m. ET. Interested parties can access live and archived presentations on the company's website. Vicarious Surgical is focused on innovative robotics technology aimed at improving surgical efficiency and patient outcomes.

Vicarious Surgical Inc. (NYSE: RBOT) will release its fourth quarter 2021 financial results on March 3, 2022, after market close. A conference call, starting at 4:30 p.m. ET, will follow to discuss the results. Investors can participate by calling 1 (646) 904 5544 domestically or +1 (929) 526 1599 internationally. Vicarious Surgical, founded in 2014, focuses on enhancing surgical efficiency and reducing healthcare costs using proprietary robotic technology.

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) will engage in a fireside chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16 at 4:00 p.m. Eastern Time. The company focuses on enhancing surgical procedures through next-generation robotic technology, which has been recognized by the FDA with a Breakthrough Device Designation. Founded in 2014, Vicarious Surgical aims to improve patient outcomes while reducing healthcare costs. The event is accessible via BTIG representatives.